Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

NIOSHTIC-2 Publications Search

Search Results

Difficulty demonstrating estradiol-mediated Erk1/2 phosphorylation in MCF-7 cells.

Authors
Brower-SL; Roberts-JR; Antonini-JM; Miller-MR
Source
J Steroid Biochem Mol Biol 2005 Sep; 96(5):375-385
NIOSHTIC No.
20028684
Abstract
While some studies report that estradiol (E2) activates extracellular-signal regulated kinase (Erk1/2) in MCF-7 breast cancer cells, others report E2 does not activate this signaling pathway. This study attempted to resolve the conflicting reports by investigating experimental variables that could impact Erk1/2 activation using a high through-put assay that quantitatively assessed Erk1/2 phosphorylation. Variables tested included: cell staging and dosing regimes with and without charcoal-stripped serum, different MCF-7 cell sublines and culture densities and several E2 formulations and solvents. Levels of phosphorylated Erk1/2 were normalized to cellular protein rather than to total Erk1/2 protein because an antibody purported to recognize total Erk1/2 preferentially reacted with non-phosphorylated Erk1/2, potentially exaggerating the apparent level of Erk1/2 activation. Dosing MCF-7 cells with E2 containing small amounts of stripped serum induced Erk1/2 phosphorylation; however, this induction was largely attributed to serum factors. E2 administered in serum-free medium did not significantly alter Erk1/2 phosphorylation under any condition tested; immunocytochemistry corroborated this conclusion. While phosphatase inhibitors generally increased Erk1/2 phosphorylation, they did not impact E2-altered Erk1/2 phosphorylation. It remains important to resolve the basis of conflicting reports regarding E2-induced Erk1/2 activation due to the potential importance of this pathway on breast cancer and other processes.
Keywords
Breast-cancer; Cancer; Quantitative-analysis; Cell-cultures; Cell-culture-techniques; Solvents
Contact
Department of Biochemistry and Molecular Pharmacology, Mary Babb Randolph Cancer Center, P.O. Box 9142, West Virginia University Health Sciences Center, Morgantown, WV 26506-9142, USA
CODEN
JSBBEZ
Publication Date
20050901
Document Type
Journal Article
Email Address
mmiller@hsc.wvu.edu
Fiscal Year
2005
NTIS Accession No.
NTIS Price
Issue of Publication
5
ISSN
0960-0760
NIOSH Division
HELD
Priority Area
Work Environment and Workforce: Mixed Exposures
Source Name
The Journal of Steroid Biochemistry and Molecular Biology
State
WV
TOP